Skip to main content

Table 2 Genotyping results with ESCC patients’ survival

From: Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma

SNPs

Patientsa

Deathsa

Genetic models

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)e

P e

rs2494938

163/112/12

48/27/7

Additiveb

1.12 (0.76–1.64)

0.566

1.14 (0.78–1.67)

0.509

Dominantc

0.92 (0.59–1.43)

0.705

0.94 (0.60–1.46)

0.776

Recessived

3.10 (1.42–6.75)

0.004

3.12 (1.43–6.83)

0.004

rs2285947

145/119/23

33/38/10

Additiveb

1.48 (1.07–2.04)

0.018

1.45 (1.05–2.01)

0.025

Dominantc

1.60 (1.03–2.48)

0.038

1.59 (1.02–2.49)

0.042

Recessived

1.77 (0.91–3.43)

0.092

1.68 (0.85–3.31)

0.135

rs2399395

242/43/2

69/12/1

Additiveb

1.06 (0.61–1.85)

0.841

0.95 (0.54–1.66)

0.851

Dominantc

1.00 (0.56–1.82)

0.989

0.90 (0.50–1.65)

0.736

Recessived

2.85 (0.40–20.48)

0.299

1.90 (0.26–14.01)

0.530

  1. Abbreviations: CI confidence interval, HR hazard ratio
  2. Values in bold indicate they are statistically different (P < 0.05)
  3. aWild homozygous type / Heterozygote / Variant homozygous type
  4. bRare homozygote versus heterozygote versus major homozygote
  5. cHeterozygote/rare homozygote versus major homozygote
  6. dRare homozygote versus heterozygote/major homozygote
  7. eAdjusted for age, gender, tumor site, TNM stage, tumor differentiation, smoking and drinking status in Cox regression model